In the early years, orthopedic startups grapple with inherent vulnerabilities, even as they nurture a vision for groundbreaking technologies and new treatments.
Bolstered by staunch supporters and investors, they radiate unyielding optimism and fervor, yet these vulnerabilities endure.
Startups have many vulnerabilities:
Scarcity of funds.
Shortage of personnel.
Young or non-existent processes (such as a QMS)
Unvalidated intellectual property.
Unproven product-market fit.
No brand recognition.
Absence of regulatory clearance.
Zero customer base.
Nonexistent sales.
Lack of a sales/distribut...
